This brand name is authorized in Ecuador, Estonia, Spain, France, Ireland, Lithuania, Malta, Netherlands, Poland, Romania, Singapore, United Kingdom
The drug GELASPAN contains a combination of these active pharmaceutical ingredients (APIs):
1
Succinylated gelatin
UNII 2G86QN327L - GELATIN, UNSPECIFIED
|
Gelatin is a colloidal plasma substitute. When used in the treatment of hypovolaemia gelatin produces significant increases in blood volume, cardiac output, stroke volume, blood pressure, urinary output and oxygen delivery. Gelatin promotes osmotic diuresis, thereby helping to protect the kidneys from the adverse effects of hypovolaemia. |
2
Sodium chloride
UNII 451W47IQ8X - SODIUM CHLORIDE
|
Sodium chloride is the principle salt involved in maintaining the osmotic tension of blood and tissues. Changes in osmotic tension influence the movement of fluids and diffusion of salts in cellular tissue. |
3
Sodium acetate trihydrate
UNII 4550K0SC9B - SODIUM ACETATE
|
|
4
Potassium chloride
UNII 660YQ98I10 - POTASSIUM CHLORIDE
|
Potassium plays a vital physiological role in maintenance of normal electrical excitability of nerve and muscle. It is also important in the genesis and correction of imbalances of acid-base metabolism. |
5
Calcium chloride dihydrate
UNII M4I0D6VV5M - CALCIUM CHLORIDE
|
Calcium is the most abundant mineral in the body, and is an essential body electrolyte. Homeostasis is mainly regulated by the parathyroid hormone, by calcitonin, and by the activated form of vitamin D. Calcium is a structural component of bones and teeth. It is also required for blood clotting, neurotransmitter release, muscle contraction and normal heartbeat. |
6
Magnesium chloride hexahydrate
UNII 02F3473H9O - MAGNESIUM CHLORIDE
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
B05AA06 | Gelatin agents | B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05A Blood and related products → B05AA Blood substitutes and plasma protein fractions |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 974-MEE-0515 |
Country: EE | Ravimiamet | Identifier(s): 1722158, 1722169 |
Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 76222 |
Country: FR | Base de données publique des médicaments | Identifier(s): 69083660 |
Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 212914, 239837 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1053843, 1053844 |
Country: MT | Medicines Authority | Identifier(s): MA223/01501 |
Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 38040 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100254217 |
Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W57829001, W57829002 |
Country: SG | Health Sciences Authority | Identifier(s): 15336P |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.